PRRT2 and breast carcinoma: Additionally, overexpression of PCK-α in MCF-7 breast cancer cells alters the expression of other PKC isoforms and decreases estrogen receptor (ER) levels8,20, potentially contributing to the switch from ER-positive to ER-negative state20.